SIGLEC7, which belongs to the sialic acid-binding immunoglobulin-like lectins (SIGLECS) family predominantly expressed in leukocytes, has been previously identified as a potential immune checkpoint in bladder cancer [42]. Here, SIGLEC7 is linked to urinary bladder carcinoma.